These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17760599)

  • 1. Laser-assisted tattoo removal with topical 5% imiquimod cream.
    Ricotti CA; Colaco SM; Shamma HN; Trevino J; Palmer G; Heaphy MR
    Dermatol Surg; 2007 Sep; 33(9):1082-91. PubMed ID: 17760599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical imiquimod in conjunction with Nd:YAG laser for tattoo removal.
    Elsaie ML; Nouri K; Vejjabhinanta V; Rivas MP; Villafradez-Diaz LM; Martins A; Rosso R
    Lasers Med Sci; 2009 Nov; 24(6):871-5. PubMed ID: 19597914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model.
    Ramirez M; Magee N; Diven D; Colome-Grimmer M; Motamedi M; Oliveira G; Zamora JG; Uchida T; Wagner RF
    Dermatol Surg; 2007 Mar; 33(3):319-25. PubMed ID: 17338690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental nonsurgical tattoo removal in a guinea pig model with topical imiquimod and tretinoin.
    Solis RR; Diven DG; Colome-Grimmer MI; Snyder N; Wagner RF
    Dermatol Surg; 2002 Jan; 28(1):83-6; discussion 86-7. PubMed ID: 11998793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
    Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
    Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the S-Caine Peel for induction of local anesthesia for laser-assisted tattoo removal: randomized, double-blind, placebo-controlled, multicenter study.
    Chen JZ; Jacobson LG; Bakus AD; Garden JM; Yaghmai D; Bernstein LJ; Geronemus RG
    Dermatol Surg; 2005 Mar; 31(3):281-6. PubMed ID: 15841627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.
    Berman B; Harrison-Balestra C; Perez OA; Viera M; Villa A; Zell D; Ramirez C
    J Drugs Dermatol; 2009 May; 8(5):455-8. PubMed ID: 19537368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles.
    Hanke CW; Beer KR; Stockfleth E; Wu J; Rosen T; Levy S
    J Am Acad Dermatol; 2010 Apr; 62(4):573-81. PubMed ID: 20133012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a transparent perfluorodecalin-infused patch as an adjunct to laser-assisted tattoo removal: A pivotal trial.
    Biesman BS; Costner C
    Lasers Surg Med; 2017 Apr; 49(4):335-340. PubMed ID: 28319270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
    Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
    J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
    Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
    Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tattoo removal using the alexandrite laser.
    Fitzpatrick RE; Goldman MP
    Arch Dermatol; 1994 Dec; 130(12):1508-14. PubMed ID: 7986123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.
    Lebwohl M; Dinehart S; Whiting D; Lee PK; Tawfik N; Jorizzo J; Lee JH; Fox TL
    J Am Acad Dermatol; 2004 May; 50(5):714-21. PubMed ID: 15097955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles.
    Swanson N; Abramovits W; Berman B; Kulp J; Rigel DS; Levy S
    J Am Acad Dermatol; 2010 Apr; 62(4):582-90. PubMed ID: 20133013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tattoo approaches in dermatology.
    Luebberding S; Alexiades-Armenakas M
    Dermatol Clin; 2014 Jan; 32(1):91-6. PubMed ID: 24267425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses.
    Zeichner JA; Stern DW; Uliasz A; Itenberg S; Lebwohl M
    J Am Acad Dermatol; 2009 Jan; 60(1):59-62. PubMed ID: 18937999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional Laser-Assisted Topical Imiquimod 5% Cream Treatment for Recalcitrant Common Warts in Children: A Pilot Study.
    Park SM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
    Dermatol Surg; 2016 Dec; 42(12):1340-1346. PubMed ID: 27598444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
    Zeng Y; Zheng YQ; Wang L
    J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid tattoo removal technique using a combination of pulsed Er:YAG and Q-Switched Nd:YAG in a split lesion protocol.
    Sardana K; Ranjan R; Kochhar AM; Mahajan KG; Garg VK
    J Cosmet Laser Ther; 2015; 17(4):177-83. PubMed ID: 25588039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.